Biofrontera Inc.
BFRI
$1.08
-$0.02-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.75% | 5.11% | 11.20% | 14.27% | 9.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.75% | 5.11% | 11.20% | 14.27% | 9.54% |
| Cost of Revenue | -41.08% | -29.28% | -12.80% | 4.70% | 6.67% |
| Gross Profit | 64.26% | 43.72% | 37.46% | 24.24% | 12.54% |
| SG&A Expenses | 13.40% | 9.12% | 2.73% | -13.50% | -10.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.72% | 0.11% | 2.63% | -2.18% | -1.61% |
| Operating Income | 34.08% | 9.02% | 13.41% | 26.77% | 19.39% |
| Income Before Tax | 40.75% | -36.90% | -22.81% | 50.15% | 11.83% |
| Income Tax Expenses | 23.81% | 27.78% | 25.00% | 90.00% | 50.00% |
| Earnings from Continuing Operations | 40.67% | -36.89% | -22.81% | 50.09% | 11.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.67% | -36.89% | -22.81% | 50.09% | 11.78% |
| EBIT | 34.08% | 9.02% | 13.41% | 26.77% | 19.39% |
| EBITDA | 33.25% | 7.13% | 12.20% | 26.55% | 19.47% |
| EPS Basic | 71.29% | 18.58% | 62.70% | 87.10% | 74.11% |
| Normalized Basic EPS | 69.17% | 65.37% | 69.41% | 87.20% | 69.35% |
| EPS Diluted | 71.29% | 18.58% | 62.70% | 87.10% | 74.11% |
| Normalized Diluted EPS | 69.17% | 65.37% | 69.41% | 87.20% | 69.35% |
| Average Basic Shares Outstanding | 84.39% | 119.90% | 158.26% | 221.56% | 255.56% |
| Average Diluted Shares Outstanding | 84.39% | 119.90% | 158.26% | 221.56% | 255.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |